Karyopharm Therapeutics Inc.
US ˙ NasdaqGS ˙ US48576U1060

SecurityKPTI / Karyopharm Therapeutics Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in KPTI / Karyopharm Therapeutics Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Karyopharm Therapeutics Inc. (US:KPTI) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 32,868 shares of Karyopharm Therapeutics Inc.. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (KPTI) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

KPTI / Karyopharm Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F KARYOPHARM THERAPEUTICS COM 48576U205 0 -100.00 0
2026-02-11 2025-12-31 13F KARYOPHARM THERAPEUTICS COM 48576U205 32,868 27,006 460.70 242 0.0001
2025-11-12 2025-09-30 13F KARYOPHARM THERAPEUTICS COM 48576U205 5,862 -2,371 -28.80 0 0.0000
2025-08-05 2025-06-30 13F KARYOPHARM THERAPEUTICS COM 48576U205 8,233 8,233 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-12 2025-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 0 -100.00 0 n/a n/a n/a
2025-02-11 2024-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 55,000 -65.01 0 n/a n/a n/a
2024-11-08 2024-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 157,200 -7.69 0 n/a n/a n/a
2024-07-25 2024-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 170,300 547.53 0 n/a n/a n/a
2024-04-25 2024-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 26,300 1,543.75 0 n/a n/a n/a
2024-02-02 2023-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 1,600 -38.46 0 n/a n/a n/a
2023-11-01 2023-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 2,600 -89.12 0 n/a n/a n/a
2023-08-04 2023-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 23,900 151.58 0 n/a n/a n/a
2023-04-27 2023-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 9,500 -54.98 0 n/a n/a n/a
2023-02-02 2022-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 21,100 14.67 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 18,400 -77.59 100 -72.97 n/a n/a n/a
2022-08-03 2022-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 82,100 -27.92 370 -55.90 n/a n/a n/a
2022-05-02 2022-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 113,900 51.66 839 74.07 n/a n/a n/a
2022-02-23 2021-12-31 13F/A KARYOPHARM THERAPEUTICS CALL Call 75,100 464.66 482 241.84 n/a n/a n/a
2022-02-04 2021-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 13,300 141 n/a n/a n/a
2021-10-28 2021-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 13,300 0.00 141 2.92 n/a n/a n/a
2021-08-12 2021-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 13,300 5,511.81 137 n/a n/a n/a
2021-04-26 2021-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 237 -37.30 0 -100.00 n/a n/a n/a
2021-02-02 2020-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 378 -19.57 585 -14.72 n/a n/a n/a
2020-10-14 2020-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 470 70.91 686 31.92 n/a n/a n/a
2020-07-13 2020-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 275 -77.16 520 -77.51 n/a n/a n/a
2020-04-29 2020-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 1,204 69.58 2,312 69.88 n/a n/a n/a
2020-02-05 2019-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 710 22.20 1,361 143.91 n/a n/a n/a
2019-10-15 2019-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 581 388.24 558 685.92 n/a n/a n/a
2019-07-26 2019-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 119 36.78 71 42.00 n/a n/a n/a
2019-04-18 2019-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 87 148.57 50 56.25 n/a n/a n/a
2019-01-16 2018-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 35 -66.98 32 -82.22 n/a n/a n/a
2018-10-23 2018-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 106 202.86 180 205.08 n/a n/a n/a
2018-07-30 2018-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 35 -60.23 59 59.46 n/a n/a n/a
2018-04-26 2018-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 88 158.82 37 516.67 n/a n/a n/a
2018-01-10 2017-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 34 6.25 6 200.00 n/a n/a n/a
2017-10-25 2017-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 32 -82.32 2 -92.59 n/a n/a n/a
2017-07-12 2017-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 181 108.05 27 -25.00 n/a n/a n/a
2017-04-21 2017-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 87 26.09 36 1,100.00 n/a n/a n/a
2017-01-11 2016-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 69 -37.84 3 -86.36 n/a n/a n/a
2016-10-07 2016-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 111 640.00 22 633.33 n/a n/a n/a
2016-07-18 2016-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 15 -76.56 0 -100.00 n/a n/a n/a
2016-04-14 2016-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 64 -5.88 1 -66.67 n/a n/a n/a
2016-01-20 2015-12-31 13F KARYOPHARM THERAPEUTICS CALL Call 68 2,166.67 3 200.00 n/a n/a n/a
2015-10-08 2015-09-30 13F KARYOPHARM THERAPEUTICS CALL Call 3 -91.43 0 -100.00 n/a n/a n/a
2015-07-08 2015-06-30 13F KARYOPHARM THERAPEUTICS CALL Call 35 218.18 0 -100.00 n/a n/a n/a
2015-04-21 2015-03-31 13F KARYOPHARM THERAPEUTICS CALL Call 11 3 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-11 2024-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2024-11-08 2024-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 2,200 -4.35 0 n/a n/a n/a
2024-07-25 2024-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 2,300 -79.65 0 n/a n/a n/a
2024-04-25 2024-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 11,300 -52.92 0 n/a n/a n/a
2024-02-02 2023-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 24,000 0 n/a n/a n/a
2023-11-01 2023-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2023-08-04 2023-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 4,000 -34.43 0 n/a n/a n/a
2023-04-27 2023-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 6,100 -69.80 0 n/a n/a n/a
2023-02-02 2022-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 20,200 33.77 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 15,100 -42.80 82 -31.09 n/a n/a n/a
2022-08-03 2022-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 26,400 0.38 119 -38.34 n/a n/a n/a
2022-05-02 2022-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 26,300 -39.82 193 -31.07 n/a n/a n/a
2022-02-23 2021-12-31 13F/A KARYOPHARM THERAPEUTICS PUT Put 43,700 375.00 280 188.66 n/a n/a n/a
2022-02-04 2021-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 9,200 97 n/a n/a n/a
2021-10-28 2021-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 9,200 0.00 97 3.19 n/a n/a n/a
2021-08-12 2021-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 9,200 7,379.67 94 n/a n/a n/a
2021-04-26 2021-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 123 161.70 0 -100.00 n/a n/a n/a
2021-02-02 2020-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 47 -55.66 72 -53.25 n/a n/a n/a
2020-10-14 2020-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 106 43.24 154 10.00 n/a n/a n/a
2020-07-13 2020-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 74 -50.99 140 -51.72 n/a n/a n/a
2020-04-29 2020-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 151 -73.65 290 -73.59 n/a n/a n/a
2020-02-05 2019-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 573 258.12 1,098 617.65 n/a n/a n/a
2019-10-15 2019-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 160 -53.89 153 -26.09 n/a n/a n/a
2019-07-26 2019-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 347 123.87 207 130.00 n/a n/a n/a
2019-04-18 2019-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 155 8.39 90 -32.33 n/a n/a n/a
2019-01-16 2018-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 143 95.89 133 7.26 n/a n/a n/a
2018-10-23 2018-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 73 231.82 124 235.14 n/a n/a n/a
2018-07-30 2018-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 22 0.00 37 516.67 n/a n/a n/a
2018-04-26 2018-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 22 175.00 6 n/a n/a n/a
2018-01-10 2017-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 8 -82.61 0 -100.00 n/a n/a n/a
2017-10-25 2017-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 46 15.00 2 -75.00 n/a n/a n/a
2017-07-12 2017-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 40 -92.23 8 -88.57 n/a n/a n/a
2017-04-21 2017-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 515 3,118.75 70 6,900.00 n/a n/a n/a
2017-01-11 2016-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 16 -42.86 1 0.00 n/a n/a n/a
2016-10-07 2016-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 28 2,700.00 1 0.00 n/a n/a n/a
2016-07-18 2016-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 1 0.00 1 0.00 n/a n/a n/a
2016-04-14 2016-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 1 0.00 1 0.00 n/a n/a n/a
2016-01-20 2015-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-10-08 2015-09-30 13F KARYOPHARM THERAPEUTICS PUT Put 11 -56.00 16 23.08 n/a n/a n/a
2015-07-08 2015-06-30 13F KARYOPHARM THERAPEUTICS PUT Put 25 316.67 13 85.71 n/a n/a n/a
2015-04-21 2015-03-31 13F KARYOPHARM THERAPEUTICS PUT Put 6 -85.00 7 600.00 n/a n/a n/a
2015-03-04 2014-12-31 13F KARYOPHARM THERAPEUTICS PUT Put 40 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.